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Abstract
Background: The medicinal plants Vincetoxicum arnottianum (VSM), Berberis orthobotrys (BORM), Onosma hispida
(OHRM and OHAM) and Caccinia macranthera (CMM) are used traditionally in Pakistan and around the world for
the treatment of various diseases including cancer, dermal infections, uterine tumor, wounds etc. The present study
focuses on the investigation of the selected Pakistani plants for their potential as anticancer agents on human bone
and breast cancer cell lines in comparison with non-tumorigenic control cells.
Methods: The antitumor evaluation was carried out on human bone (MG-63, Saos-2) and breast cancer cell lines
(MCF-7, BT-20) in contrast to non-tumorigenic control cells (POB, MCF-12A) via cell viability measurements, cell cycle
analysis, Annexin V/PI staining, microscopy based methods as well as migration/invasion determination, metabolic
live cell monitoring and western blotting.
Results: After the first initial screening of the plant extracts, two extracts (BORM, VSM) revealed the highest potential
with regard to its antitumor activity. Both extracts caused a significant reduction of cell viability in the breast and bone
cancer cells in a concentration dependent manner. The effect of VSM is achieved primarily by inducing a G2/M arrest
in the cell cycle and the stabilization of the actin stress fibers leading to reduced cell motility. By contrast BORM’s
cytotoxic properties were caused through the lysosomal-mediated cell death pathway indicated by an upregulation
of Bcl-2 expression.
Conclusions: The antitumor evaluation of certain medicinal plants presented in this study identified the methanolic
root extract of Berberis orthobotrys and the methanolic extract of Vincetoxicum arnottianum as promising sources for
exhibiting the antitumor activity. Therefore, the indigenous use of the herbal remedies for the treatment of cancer
and cancer-related diseases has a scientific basis. Moreover, the present study provides a base for phytochemical
investigation of the plant extracts.
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Background
Natural products have historically and continually been
investigated for promising new leads in pharmaceutical
development. Cancer is a major public health problem
worldwide with millions of new cancer patients diag-
nosed each year and many deaths resulting from this
disease. Chemotherapy remains the principal mode of
treatment for various cancers. Researchers have focused
on the anticancer activity of the plants because the
medicinal plants are used in different countries for the
treatment and prevention of cancer [1, 2]. For example,
Traditional Chinese medicine (TCM) is used as an adju-
vant therapy to alleviate cancer symptoms at the terminal
stages when Western medicine treatments cannot offer
any other treatment options [3, 4].
In Pakistan, as in other developing countries, traditional
medicines are in widespread use; with the practitioners
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formulating and dispensing the recipes to their patients.
The medicaments are prepared most often from a
combination of two or more plant products which may
contain active chemical constituents with multiple
physiological and pharmacological activities and could
be used in treating various disease conditions. The
discovery of effective herbs and elucidation of their
underlying mechanisms could lead to the development
of an alternative and complementary method for can-
cer prevention and/or treatment. Based on an analysis
of published literature, we selected four traditional
Pakistani plants with medicinal value to evaluate their
anticancer efficacy. In search of the target plant extracts
for the development of anticancer drugs, here we have
investigated Vincetoxicum arnottianum, Berberis ortho-
botrys, Onosma hispida and Caccinia macranthera of
Pakistan origin.
Vincetoxicum arnottianum Wight (Syn: Cyanchum
arnottianum Wight) is a perennial plant of the Apocyna-
ceae family found in different parts of Pakistan including
Hazara, Swat, Kaghan, Shinkiari, Kashmir etc. [5]. The
family Apocynaceae is one of the largest angiosperm
family comprising 375 genera and over 5100 species.
Plants of the family Apocynaceae have been reported to
be extensively used for the treatment of the skin dis-
eases, pimples [6], malaria, diabetes and diarrhea and
most importantly some species have been used in cancer
chemotherapy [7]. Some species of Vincetoxicum have
exhibited very high cytotoxicity against brine shrimps
[16], antidiarrheal and antispasmodic [8], antibiotic [9],
anti-inflammatory [10], antidiabetic and antioxidant [11]
activities etc. Alkaloids are normally reported from vari-
ous Vincetoxicum species [12, 13]. The plant V. arnottia-
num (syn. C. arnottianum) has been reported for the
treatment of maggots in wounds of cattle, horses and
sheep [14], wounds and injuries [15] etc.
Berberis orthobotrys Bien ex Aitch. is a shrub that be-
longs to the family Berberidaceae. Berberidaceae family
comprises 13 genera and 650 species [25] and it is repre-
sented in Pakistan by 3 genera and 22 species. Various
species of the genus Berberis are reported from different
parts of Pakistan i.e. Gilgit, Baltistan, Chitral, Skardu,
Astor etc. Hussain et al. [16] have studied the diversity
and ecological characteristics of different plants in-
cluding B. orthobotrys. Mokhber-Dezfuli et al. [17] and
Srivastava et al. [18] have reviewed on the chemical
and biological diversity in Berberis. The plant B. ortho-
botrys has been reported for the treatment of ulcer,
stomach problems, kidney stones, uterine tumor,
wounds [19], blood purification, jaundice, urine prob-
lem, diarrhea [20], gastrointestinal diseases [21] etc.
Moreover the plant B. orthobotrys has revealed various
biological activities including antihypertensive [22],
cardiac depressant [23], antihyperlipidemic [24] etc.
The chemical constituents that are reported from B.
orthobotrys include alkaloids [25].
Onosma hispida Wall. ex G. Don. is a perennial herb
of the Boraginaceae family found in different localities in
Pakistan including Gilgit, Chitral, Baluchistan, Swat,
Hazara etc. Kumar et al. [26] have reviewed the genus
for its phytochemical and pharmacological aspects. The
genus Onosma L. is one of the largest and most species-
rich genera of the family Boraginaceae comprising more
than 150 species [27–29]. O. hispida is used as a medi-
cinal herb [30, 31] exhibiting various biological proper-
ties including antibacterial activity [32]. The plant O.
hispida has been reported to be used as blood purifier
and for cuts, swells, wounds [33]. And it has also been
reported for the treatment of abdominal ulcers, hair
problems, bladder and kidney stones and rheumatism
[34], pneumonia, typhoid fever and also used for dyeing
hairs [35]. A number of chemical constituents including
benzoic acid derivatives, apigenin derivatives, flavones
and flavanone derivatives have been isolated from O.
hispida [26].
Caccinia macranthera (Banks & Sol.) Brand (Syn: Bor-
ago macranthera Banks & Sol.) is a leafy perennial plant
of the Boraginaceae family found in Baluchistan province
in Pakistan [36]. The roots of C. macranthera have been
reported to be used for the treatment of dermal infections,
liver disorders and dyspepsia and some other traditional
uses [37, 38], sedative, treatment of cough, expectorant
[39]. Moreover, the leaves of C. macranthera have also
been reported for its medicinal properties [40]. The Bora-
ginaceae is a large family that comprises approximately
205 genera and 2500 species worldwide [41]. The root
extract of C. macranthera was studied for induction of
phage production [42]. Different chemical constituents
including glycosides [43], pyrrolizidine alkaloids [44],
triterpenoid sapogenin [45] have been reported from the
species of the genus Caccinia other than C. macranthera.
However El-Shazly & Wink have reported that pyr-
rolizidine alkaloids are commonly found in Boragina-
ceae family. However, the overview about the medicinal
plants Vincetoxicum arnottianum, Berberis orthobotrys,
Onosma hispida and Caccinia macranthera of Pakistan
origin is given in Table 1.
Despite their widespread use, however, no scientific as-
sessment for anticancer effect has been conducted in
most cases. Considering their increasing recognition and
consumption, the present study was undertaken to
evaluate the anticancer potential of these plant extracts
in the inhibition of cell proliferation, induction of cell
death, metabolic alterations and structural modifications
in human breast (MCF-7, BT-20) and bone (MG-63,
Saos-2) cancer cell lines. As a kind of control, non-
tumorigenic cell lines of the breast (MCF-12A) and bone
(POB) were included in the screening.
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Methods
Plant material collection and identification
Four plants were employed in the present study. Vince-
toxicum arnottianum and Caccinia mancranthera were
collected from Baluchistan (Pakistan) and Berberis ortho-
botrys and Onosma hispida were collected from Gilgit-
Baltistan (Pakistan) in 2014 (Table 1). The plants were
identified by Dr. Sher Wali Khan and reference speci-
mens were deposited at the Department of Biological
Sciences, Karakoram International University, Pakistan.
Preparation of extracts
Each plant sample including the aerial part of V. arnot-
tianum (VSM), root (BORM) and fruit (BOFM) parts of
B. orthobotrys, root (OHRM) and aerial (OHAM) parts
of O. hispida, and the aerial part of C. macranthera
(CMM) were air dried in shade and mechanically ground
to fine powder. The finely-powdered material of each
plant was soaked in methanol for several days and ex-
tracted. The dried methanolic extracts were obtained by
removing the methanol by evaporation under reduced
pressure. Furthermore, the fruit extract (BOFM) of B.
orthobotrys was fractionated using solvent-solvent ex-
traction and yielding n-hexane soluble oily substance
(BO-23) and ethylacetate soluble oily substance (BO-5).
Finally, eight samples i.e. VSM, BORM, BOFM, BO-5,
BO-23, OHRM, OHAM and CMM were obtained and
used for further study. Then, 50 mg of each dry sample
was dissolved in 1 ml DMSO, EtOH or MeOH for the
antitumor activity tests.
Chemicals
For soaking and extraction purposes, the commercial
grade solvents were used. For preparation of the samples
for the antitumor activity, absolute ethanol, DMSO, and
absolute methanol from Sigma Aldrich were employed.
Cell lines, culturing and treatment conditions
Human osteosarcoma cell lines MG-63 (CRL-1427),
Saos-2 (HTB-85) and human breast adenocarcinoma cell
lines MCF-7 (ATCC: HTB-22), BT-20 (HTB-19) as well
as non-tumorigenic human epithelial breast cell line
MCF-12A (CRL-10782) were purchased from ATCC
(http://www.lgcstandards-atcc.org/) under the given num-
bers. The human non-tumorigenic, primary osteoblast
cells (POB) were chosen as control cells. Briefly, cells were
isolated from the spongiosa of the femoral heads of
patients undergoing primary total hip replacement. The
samples were collected with patient agreement and ap-
proval by the Local Ethical Committee (registration
number: A 2010-10). Human primary osteoblasts were
already used and isolation procedure was already de-
scribed [46]. Except for MCF-12A, all other cell lines
and the primary POB cells were cultivated in Dulbecco’s
modified Eagle’s medium (Invitrogen, Germany) with
10 % fetal bovine serum (PAN Biotech GmbH, Germany)
and 1 % gentamycin (Ratiopharm, Germany). MCF-12A
was grown in Dulbecco’s modified Eagle’s medium
Ham’s F12 without phenol red (Invitrogen, Germany)
containing 10 % horse serum (PAA Laboratories GmbH,
Germany), the Mammary Epithelial Cell Growth Medium
SupplementPack (PromoCell, Germany) including Bovine
Pituitary Extract 0.004 nl/ml, Epidermal Growth Factor
(recombinant human) 10 ng/ml, Insulin (recombinant
human) 5 g/ml, Hydrocortisone 0.5 g/ml and 1 % genta-
mycin (Ratiopharm, Germany).
Prior treatment with the plant extract cells were
adapted to phenol-red-free Dulbecco’s modified Eagle’s
medium (PAA Laboratories GmbH, Germany) with 10 %
charcoal stripped fetal bovine serum (PAN Biotech
GmbH, Germany) for 48 h to avoid unspecific stimulation
of endogenous hormones in the serum (assay medium).
Treatment with plant extracts (final concentration 1, 10,
Table 1 Overview of the selected Pakistani plants used in this study
Plant name Sample code Description Family Medicinal uses
Vincetoxicum
arnottianum Wight




BORM Methanolic root extract of the plant. Berberidaceae Uterine tumor, wounds, gastrointestinal
problems, ulcer, blood purification, jaundice,
urine problem, diarrhea, antihypertensive,
cardiac depressant, antihyperlipidemic etc
BOFM Methanolic extract of the flowers of the plant
BO-5 Ethylacetate soluble oily substance extracted from
the methanolic fruit extract of the plant.
BO-23 n-hexane soluble oily substance extracted from
the methanolic fruit extract of the plant.
Onosma hispida
Wall. ex G. Don.
OHRM Methanolic root extract of the plant. Berberidaceae Wounds, cuts, swells, abdominal ulcer,
antibacterial, blood purifier, hair problems,
dying hair, bladder and kidney stones,
rheumatism, pneumonia, typhoid fever etc.
OHAM Methanolic extract of the aerial parts of the plant.
Caccinia macranthera
(Banks & Sol.) Brand
CMM Methanolic extract of the plant. Boraginaceae Dermal infections, liver disorders, dyspepsia,
sedative, cough, expectorant, induction of
phage production etc
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25, 50, and 100 μg/ml) was carried out for 48 h in assay
medium. As negative control substance the vehicle
DMSO, ethanol or methanol (0.1 %) was used in the
same manner.
Viability assay and calculation of IC50 values
MTS (3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymeth-
oxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assay to
determine cell viability was performed according to
manufactures protocol (CellTiter 96® AQueous One So-
lution Cell Proliferation Assay; Promega Corp., Madison,
WI, USA). Briefly, cells were seeded in 96-well plates at
a density of 2000 cells/well in 100 μl medium and left to
attach for 24 h. Treatment with plant extracts at final
concentrations of 1, 10, 25, 50 and 100 μg/ml was car-
ried out as described previously [47]. In parallel, control
approaches were carried out with medium only and
0.1 % of the solvent DMSO, EtOH or MeOH to calculate
background absorbance. No background absorbance was
obtained for the extracts and MTS in the absence of
cells, as some extracts are capable of reducing the MTS.
After an initial incubation for 24 h cells were assayed
with MTS. Colorimetric changes were measured at
490 nm and raw data was transferred to Microsoft Excel
and analyzed. At least 8 replicates corrected with the
background absorbance were performed. Reduction of
cell viability at each concentration was plotted as a dose
response curve. The IC50 values were calculated using
nonlinear regression to fit data to the dose–response.
Cell cycle analysis
Proliferation alterations as well as apoptosis induction
under the exposure of the plant extracts were estimated
by cell cycle analysis via flow cytometry (FACS Calibur,
BD Biosciences) after propidium iodide (Roche Diagnos-
tics, IN, USA) staining (50 mg/ml) of the cells as already
described [47, 48]. For data acquisition and histogram
preparation, the software FlowJo version 7.6.5 (Tree Star;
www.flowjo.com) was used. A minimum of 15,000
ungated events were recorded. Doublets and clumps
were excluded by gating on the DNA pulse width ver-
sus pulse area displays. For statistical evaluation, the
sum of cells in S- and G2/M-phase was defined as pro-
liferative events and the sub-G1-peak of the histogram
as apoptotic ones.
Annexin V/PI apoptosis detection
Annexin-V detects the translocation of phosphatidylser-
ine from the inner leaflets to the outer leaflets of the
plasma membrane, which is a key feature of apoptotic
cells, whereas PI detects necrotic cells with perme-
abilized plasma membrane. Labeling of early apoptotic
and dead cells was performed according to the manu-
facturers’ instructions from the Alexa Fluor488 Annexin
V/Dead Cell Apoptosis Kit (Thermo Fisher Scientific
Inc., Germany). Cells were treated with 100 μg/ml plant
extract for 48 h. After treatment detached as well as ad-
herent cells were washed twice with cold PBS. The cell
pellet was resuspended in 100 μl of annexin binding
buffer at a density of 1 × 106 cells per ml and incubated
with 5 μl of Alexa488-conjugated Annexin-V and 5 μl of
PI for 15 min at room temperature in the dark. 400 μl
of 1× binding buffer was added to each sample tube,
and the samples were immediately analyzed by flow cy-
tometry. Histograms and statistics were designed with
the software FlowJo Version 7.6.5.
Microscopy
For bright field as well as fluorescence microscopic im-
aging, cells were seeded on glass cover slips and cultured
for 24 h. After treatment with plant extracts bright field
images were obtained using Axio Scope A1 microscope
and the software AxioVision Imaging Software Release
4.8.2. (Carl Zeiss, Germany). For fluorescence imaging
cell were fixed with 4 % paraformaldehyde for 15 min,
followed by three washings with PBS and then perme-
abilized with 0.1 % Triton X-100 for 15 min. After care-
fully washing, cells were incubated with 100 μl 6.6 μM
Alexa Fluor594 phalloidin (Invitrogen, Germany) for
60 min in the dark at room temperature, washed again,
counterstained with DAPI (Roche Diagnostics GmbH,
Germany) for 15 min. Finally, cell were washed four
times with PBS and embedded in mounting medium. Ly-
sosomes were labeled with LysoTracker® Green DND-26
(Molecular Probes, Carlsbad, CA, USA) following the
protocol supplied. The other cell compartments: mito-
chondria (MitoTracker® Mitochondrion-Selective Probes
Green FM), Golgi complex (BODIPY® FL C5-ceramide
complexed to BSA), endoplasmic reticulum (ER-Tracker™
Green BODIPY® FL glibenclamide), neutral lipids (4,4-di-
fluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene
BODIPY® 493/503), all from Molecular Probes, Germany
were labeled following the manufactures’ instructions. All
fluorescence signals were investigated with an inverted
confocal laser scanning microscope (LSM780, Carl Zeiss,
Germany) equipped with a helium/neon-ion laser and a
ZEISS 63 × oil immersion objectives. The confocal images
(1024 × 1024 pixel) were optimized using the ZEN software
(Carl Zeiss, Germany).
Scanning electron microscopy
For scanning electron microscopy (SEM) cells grown on
glass cover slips were fixed with 2 % glutaraldehyde and
1 % PFA in 0.1 M phosphate buffer pH 7.3. After washes
in 0.1 M phosphate buffer the cells were dehydrated
with a graded series of ethanol and were processed for
critical point drying using CO2 as intermedium (Emitech
K850 critical point dryer, Emitech Ltd. Ashford, UK).
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The cover slips were mounted on SEM stubs with
adhesive carbon tape (Plano, Wetzlar, Germany) and
sputter-coated with a gold layer (approximately 15–20 nm
thickness) using a Bal-Tec SCD004 sputter coater (Balzers
Union Ltd., Balzers, Liechtenstein). Specimens were
viewed in a field-emission SEM operated at 5 kV (Merlin
VP compact, Carl Zeiss Microscopy, Jena, Germany) and
images with a size of 1024 x 768 pixels were recorded.
Morphometric measurements of cell body axis length and
width were taken with the free line measurement tool on
calibrated pictures imported into iTEM imaging software
(Olympus Soft Imaging Solutions, Münster, Germany).
Mitochondrial O2-consumption
Mitochondrial O2-consumption as a measure for re-
spiratory activity was determined by the Bionas® 2500
analyzing system combined with the metabolic chip Bio-
nas DisocveryTM SC1000 equipped with Clark-type oxy-
gen sensors. Prior experiments, chips were cleaned with
70 % ethanol for 10 min, washed with PBS and were
adapted to the measurement medium for 5 min. Meas-
urement medium was composed of DMEM without
NaHCO3 (Invitrogen, Germany), 0.1 % charcoal stripped
fetal bovine serum (PAN Biotech GmbH, Germany) and
1 % gentamycin (Ratiopharm, Germany), pH value 7.4
and sterile filtered. On each chip 2x106 cells were seeded
and let them adhere over night at 37 °C and in 5 % CO2
so that 80 % sub-confluence on the sensor chips was
reached. Bionas measurements were carried out with a
pump rate of 56 ml/min [49]. After an adaption phase of
2 h to the new culture conditions, extracellular oxygen
consumption of MG-63 cells after application of 25 μg/
ml BORM or VSM was measured continuously for 20 h.
Thereafter the recovery status (measurement medium
without plant extracts) of the cells was monitored for
additional 24 h. Data sets were evaluated and normalized
with the software Bionas15002 Data analyzerV1.07.
Migration and invasion
Influence on migration was conducted on MG-63 cells,
pre-incubated in assay medium for 48 h adaption in 6-
well plates (Greiner, Germany). A scratch wound was
made by Ibidi culture inserts (μ-Dish 35 mm; Ibidi
GmbH, Martinsried, Germany) following the instructors
recommendations. When cell layers reached confluence,
the culture insert was removed and cells were treated
with VSM (25–50 μg/ml) extract or control (vehicle,
DMSO). Gap closure was analyzed as described previ-
ously [50]. Cell invasion assay was performed with the
CytoSelect™ 24 –Well Cell Invasion Assay (Basement
Membrane, Fluorometric Format) from Cell Biolabs,
Inc., CA, USA. Briefly, 1x106 MG-63 cells with the plant
extracts were seeded in the membrane insert for 48 h.
Fluorescence of invaded cells was counted with a plate
reader at 480/520 nm.
Western blotting procedure
The general steps of the Western blot procedure have
been described previously [49]. Briefly, after treatment
with the plant extracts VSM and BORM for at least 48 h
the cells were trypsinized, washed with PBS and lysed in
ice-cold lysis buffer (Bio-Plex Cell Lysis Kit, Bio-Rad,
USA). After SDS-PAGE, protein content per lane as well
separation quality was controlled with the Criterion
Stain FreeTM gel imaging system (Bio-Rad, Germany).
For protein detection primary antibodies (PCNA: sc-56,
from Santa Cruz, USA; BCL-2: B3170, from Sigma) were
incubated overnight at 4 °C followed by labeling with a
horseradish peroxidase (HPR)-conjugated secondary
antibody (Dako, Glostrup, Denmark) for 1 h at room
temperature. Protein signals were visualized by using
SuperSignal West Femto Chemiluminescent Substrate
(Pierce Biotechnology, Rockford, USA). Band intensity
was analyzed densitometrically with the Molecular
Imager ChemiDoc XRS and Image Lab 3.0.1 software
(Bio-Rad, USA). Protein detection was repeated at least
three times with individually prepared cell lysates from
independently passaged cells.
Statistical analysis
Every experiment was replicated three times with indi-
vidually passaged cells and data sets were expressed as
means ± standard deviations (SD). Statistical significance
was determined by the unpaired one-way ANOVA or
t-test (***P < 0.001, **P < 0.005, *P < 0.05).
Results
Initial screening on cell viability
To evaluate the anticancer properties of the Pakistani
plant extracts two bone (MG-63, Saos-2) and two breast
(BT-20, MCF-7) cancer cell lines in comparison with
primary osteoblasts (POB-110) and non-tumorigenic
mammary epithelial cells (MCF-12A) were selected. The
osteosarcoma cell line MG-63 represents an early osteo-
blastic type while Saos-2 cells exhibited the most mature
osteoblastic phenotype [51]. The breast cancer cell line
MCF-7 represents the luminal, estrogen and progester-
one receptor-positive subtype whereas BT-20 cells are
invasive, triple-negative breast cancer cells [52]. For the
initial screening all cells were treated with 50 μg/ml of
each plant extract for 48 h and cell viability was mea-
sured right after (Fig. 1). The extracts VSM and BORM
caused the greatest significant reduction (40–60 %) of
cell viability in the osteosarcoma cell lines MG-63 and
Saos-2. On primary osteoblast cells (POB-110) VSM in-
duced only a slight decrease in cell viability while BORM
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lowered the viability up to 80 %. Beside VSM and BORM,
only the treatment with BO-5 on MG-63 cells as well as
OHRM on Saos-2 cell revealed a significant viability de-
crease of 10–15 %. These results illustrate that the VSM
extract has anticancer potential on bone cancer cells, since
it selectively reduced the vitality of osteosarcoma cells and
only exerts a minimal effect on the primary osteoblasts.
Similar results were achieved for the treatment of the
breast cancer cell lines. On BT-20, hormone-independent
and invasive carcinoma cells, only the BORM extract
caused a slight viability reduction of approximately 20 %.
On MCF-7 cells, VSM as well as BORM induced de-
creased vitality rate in a range of 10–20 %. This vitality
reduction was also measured on the non-tumorigenic
control cell line MCF-12A indicating that the extracts
VSM and BORM displayed strong cytotoxic effects
which will be analyzed in the next sections.
Influence on cell cycle phases of MG-63 osteosarcoma cells
Besides the vitality measurements, the influence on cell
growth and the induction of apoptosis are important pa-
rameters to evaluate the respective anticancer properties
of the plant extracts. Therefore, cell cycle analyses were
performed to determine the influence on the prolifera-
tion behavior (G2/M + S phase) and apoptosis initiation
by DNA strand breaks (sub G1 phase), simultaneously
(Fig. 2). Exemplarily, for all cell lines used, Fig. 2 demon-
strates the DNA histogram (Fig. 2a), proliferation alter-
ations (Fig. 2b) and the number of apoptotic cells
(Fig. 2c) after 48 h treatment with 50 μg/ml plant extract
on MG-63 osteosarcoma cell line.
Both, in the histogram and in the proliferation diagram
is clearly evident that the extracts OHRM, VSM, BO-5
and BO-23 accelerate the cell number in the proliferative
phases G2 and M. Only BORM caused a slight significant
Fig. 1 Determination of cell viability. Measurement of cell viability via MTS assay after exposure to 50 μg/ml plant extract for 48 h on respective
bone (MG-63, Saos-2) and breast (BT-20, MCF-7) cancer cell lines in comparison with primary osteoblasts (POB) and non-tumorigenic mammary
epithelial cells (MCF-12A). As control treatment the vehicle DMSO and MeOH were used at a final concentration of 0.1 % (w/v). Samples were
compared using one-way ANOVA. Error bars indicated mean ± SD, n = 8, ***P < 0.001, **P < 0.01, *P < 0.5, significantly different compared to control
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Fig. 2 Cell cycle alterations of MG-63 cells. a Histogram of the cell cycle distribution of MG-63 cells after treatment with the control substance (c)
and the eight samples of plant extracts at a concentration of 50 μg/ml for 48 h. G1, S, G2/M and sub-G1 phases are marked with black arrows.
Represented were the most prominent samples of 3–5 individual replicates. b Calculation of proliferation after treatment with the vehicle
(DMSO, EtOH, MeOH; equates to 100 %) and the plant extracts at a concentration of 50 μg/ml for 48 h. As proliferative phases the sum of S
and G2/M phases were calculated in percentages. c As apoptotic fraction the sub G1-peak was measured. (mean ± SD, n = 3–5, ***P < 0.001,
**P < 0.01, *P < 0.5, significantly different compared to control, one-way ANOVA)
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reduction in the proliferative phases (20 %). The number
of apoptotic cells increased after treatment with 50 μg/ml
of BOFM, VSM, CMM and BO-23, significantly. In sum-
mary, some of the plant extracts display an effect on the
proliferative phases G2/M and S, but do not affect the
sub-G1 phase. The DNA-histograms of the control treat-
ments with medium, DMSO, EtOH and MeOH (final con-
centration: 0.1 μg/ml) are given in Additional file 1: Figure
S1, showing no alterations in the cell cycle phases.
Concentration dependent effects of BORM and VSM
As BORM and VSM caused the most significant effects
on all bone and breast cancer cell lines, both extracts
were examined in concentration series ranging from 0.1
to 100 μg/ml to evaluate the concentration dependent
effects (Figs. 3 and 4) on cell viability and to calculate
the IC50 values (Table 2). Therefore, all the cell lines
were used in non-confluent cell cultures (confluence at
treatment beginning: 60–80 %).
Fig. 3 Concentration dependent effects of BORM. Cell viability measurement in concentration series of BORM in a range from 1 to 100 μg/ml
after exposure of 50 μg/ml plant extract for 48 h on respective bone (MG-63, Saos-2) and breast (BT-20, MCF-7) cancer cell lines in comparison
with primary osteoblasts (POB) and non-tumorigenic mammary epithelial cells (MCF-12A). The solvent DMSO was used as a negative control.
Mean ± SD, n = 6–8, ***P < 0.001, **P < 0.01, *P < 0.5, significantly different compared to control, one-way ANOVA
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BORM induced linear concentration dependent effects
on the osteosarcoma cell lines MG-63 and Saos-2 as well
as on the breast cancer cell lines BT-20 and MCF-7
(Fig. 3). The highest concentration of 100 μg/ml reduced
the cell viability by 60–80 % in all tumorigenic and con-
trol cells. However, in comparison with cancer cells, the
control cells POB-110 and MCF-12A were not that
strongly affected by BORM in concentrations below
50 μg/ml. This is confirmed by the calculation of the
IC50 values: BORM exhibited the lowest values for BT-
20 and Saos-2 (~60 and 34 μg/ml), indicating a pro-
nounced cytotoxicity (Table 2). In contrast, VSM caused
only a linear concentration dependent effect on the bone
cancer cell lines MG-63 and Saos-2 leading to IC50
values of 62.53 and 57.09 μg/ml, respectively. The IC50
value for the control primary osteoblasts POB was sig-
nificantly higher (515.76 μg/ml) indicating that VSM
mediates a stronger cytotoxic impact on the bone cancer
cell lines. The vitality of the non-tumorigenic mammary
epithelial cell line MCF-12A was only minimally affected
Fig. 4 Concentration dependent effects of VSM. Cell viability measurement in concentration series of VSM in a range from 1 to 100 μg/ml after
exposure of 50 μg/ml plant extract for 48 h on respective bone (MG-63, Saos-2) and breast (BT-20, MCF-7) cancer cell lines in comparison with primary
osteoblasts (POB) and non-tumorigenic mammary epithelial cells (MCF-12A). The solvent DMSO was used as a negative control. Mean ± SD,
n = 6–8, ***P < 0.001, **P < 0.01, *P < 0.5, significantly different compared to control, one-way ANOVA
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by VSM leading to a no calculable IC50 value. On the other
hand VSM displayed moderate IC50 values for BT-20 and
MCF-7 (132.67, 116.82). These results illustrate that the
plant extract VSM has anti-tumor potential, primarily
because the viability of the cancer cells is reduced and
the influence on the non-tumorigenic control cells is low.
These dose dependent effects were verified by cell
cycle measurements (Fig. 5a, b) and apoptosis detection
(Fig. 5c) on the osteosarcoma cell line MG-63, exemplar-
ily. In comparison with the control treatments BORM
induced a slight increase of the proliferative phase G2/
M, starting at a concentration of 10 μg/ml. In contrast,
the VSM extract caused a linear, concentration-dependent
increase in the proliferative phase G2/M and S, indicating
for a G2-arrest. At a concentration of 100 μg/ml VSM
more than half of the analyzed cells were detected in the
G2/M phase. To verify the apoptosis induction an Annexin
V/PI staining was performed (Fig. 5c, Additional file 2:
Figure S2). 100 μg/ml BORM induced an increase in early
and late apoptotic events up to 50 %. By contrast, VSM
caused a slight shift in early apoptotic events (~ 20 %). All
together, these results suggest that BORM and VSM
exhibit anti-tumorigenic potential. The precise mode of
action is to be analyzed in the next chapters.
Morphological, cytoskeletal and cell compartment
alterations
To characterize morphological and cytoskeletal changes
(F-actin and ß-tubulin), MG-63 cells were cultured in
the presence of BORM and VSM (0.1–100 μg/ml) or ve-
hicle control (0.1 % DMSO) for 48 h, and monitored by
bright field, scanning electron and laser scanning mi-
croscopy (Fig. 6; Additional file 3: Figure S3, Additional
file 4: Figure S4). Under control conditions MG-63 cells
form a confluent monolayer with the typical fibroblast-
like cell structure (Fig. 6a). Confocal imaging revealed
that untreated MG-63 cells possess cortical actin, some
well-defined stress fibers, and cell polarity as shown by
the presence of lamellipodia (Fig. 6c). VSM caused a
remarkable change in cell shape: cells are wider and have
a larger cell surface (Fig. 6b). Furthermore, a reduced
formation of the cortical cytoskeleton and a solid
reinforcement of actin stress fibers through the entire
cell area are visible. The stress fibers are much longer,
thicker and stabilize the entire cell, so that the cell con-
tacts are partially broken. Exposure to BORM resulted
in a strong increase of vesicles in the cell nucleus envir-
onment, observed both in the bright field image as well
as in the F-actin staining (Fig. 6a-c). The cells are much
more stretched and spindle-shaped, resulting in a
smaller cell area (Fig. 6b). The formation of the actin
fibers as well as the distribution of cortical actin did not
change, substantially. The formation of tubulins is nei-
ther changed after treatment with BORM nor VSM. The
increased formation of vesicles after exposure to BORM
as well as the strengthening of the actin skeleton after
treatment with VSM can be due to metabolic alteration
or cell compartment disorders. Therefore, primary cell
compartment alterations were monitored by live cell
imaging (Fig. 7). The number and distribution of mito-
chondria as well as the appearance of the endoplasmic
reticulum remained almost unchanged. But in contrast,
the exposure to BORM revealed an accumulation and
augmentation of lysosomes while treatment with VSM
reduced the amount of lysosomes, significantly. Already
at a starting concentration of 1 μg/ml the number of
Table 2 Overview of the calculated IC50 values. IC50 values of the plant extracts BORM and VSM on the bone and breast cancer cell
lines in comparison with the non-tumorigenic control cells determined by viability measurements after 48 h treatment
Engel et al. BMC Complementary and Alternative Medicine  (2016) 16:244 Page 10 of 18
Fig. 5 Cell cycle phases, proliferation and apoptosis events. Cell cycle analysis of VSM and BORM treated MG-63 cells (48 h) in concentration series
ranging from 1 to 100 μg/ml in comparison with the control treatment (DMSO). a Histograms of the cell cycle distribution. b Calculation of proliferation.
As proliferative phases the sum of S and G2/M phases were calculated in percentages. Mean ± SD, n= 3–4, ***P < 0.001, **P < 0.01, *P< 0.5, significantly
different compared to control, one-way ANOVA. c Annexin V/PI staining to label living, early and late apoptotic events after treatment with the control
(DMSO), 100 μg/ml BORM or VSM measured via flow cytometry
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Fig. 6 Morphological and cytoskeletal alterations of MG-63 cells analyzed by different microscopic techniques. a Morphological alterations of
MG-63 cells after treatment with DMSO (control) or 100 μg/ml VSM and BORM by bright field imaging (upper panel) and scanning electron
microscopy (lower panel). b Calculation of the cell size quotients by length and width measurements of the cells in the scanning electron
micrographs (left). n = 30. Enlarged section of BORM treated MG-63 cells. Distinctly, the vesicles accumulation can be detected around cell
nucleus (right). c Laser scanning microscopic images of F-actin (red) and ß-tubulin (green) stained MG-63 cells. Cells were counterstained with
Hoechst to label the cell nuclei (blue). Notably, VSM induced an increased Actin stress fiber formation through the entire cell, leading to a
greater cell surface area. In contrast, treatment with BORM caused an increased production of vesicle-like structures and a spindle-shaped
cell shape. Magnification bars = 20 μm
Engel et al. BMC Complementary and Alternative Medicine  (2016) 16:244 Page 12 of 18
Fig. 7 Structural cell compartment alterations of MG-63 cells. Laser scanning microscopic analysis of cell compartments (mitochondria, lysosomes,
Golgi apparatus, endoplasmic reticulum, and neutral lipids) within MG-63 cells treated with 100 μg/ml BORM or VSM in comparison to the control
(DMSO). Cells were counterstained with Hoechst to label the cell nuclei (blue). Notably, exposure to VSM caused a reduced production of lysosomes
and a strong increase of neutral lipids. In contrast, BORM treatment revealed an accumulation and augmentation of lysosomes, stronger granularization
and formation of Golgi vesicles and a diffuse distribution of neutral lipids
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lysosomes increased, and reached the highest number at a
concentration of 25 μg/ml BORM. Higher concentrations
of BORN did not further elevate the amount of lysosomes
but caused a merger of lysosomes so that the size in-
creased up to the 3–5 fold (Additional file 5: Figure S5).
Similarly, treatment with BORM caused a change of the
Golgi apparatus: a stronger granularisation and formation
of Golgi vesicles can be observed. The staining of neutral
lipids, which was only very slightly visible in the untreated
cells, was strongly upregulated after VSM exposure. Many
small dots of lipids could be verified around the nucleus
and in the cytoplasmic area. In contrast, treatment with
BORM resulted in a diffuse distribution of neutral lipids
in the cell without any specific dot distribution. Up to this
state, it can be concluded that BORM and VSM mediate
cytotoxic effect by affecting different metabolic pathways.
To discuss this more profound, various metabolic and
motility-specific investigations were carried out.
Influence on O2 consumption, motility and selected
protein marker expression
To examine the cell specific mode of action of the two
plant extracts, the influence on cell metabolism was in-
vestigated, firstly. Therefore, live cell monitoring of three
metabolic parameters (cell impedance, O2-consumption
and extracellular acidification) was performed (Fig. 8a,
Additional file 6: Figure S6). Both, the treatment with
VSM and BORM for 24 h resulted in a strong reduction
(VSM: 75 %, BORM: 99 %) of the mitochondrial O2-
consumption in MG-63 cells (Fig. 8a). This decrease in
respiratory capacity cannot be reverted after the discon-
tinuation of the plant extracts. In contrast, the effect on
primary osteoblasts (POB) was different: VSM did not
alter the respiration capacity; BORM induced a slight
decrease in O2-consumption (~ 20 %) which could not
only be reverted but enhanced up to 100 % after dis-
continuation of the plant extract. Beside this strong
effect on cellular energy metabolism, the effect on cell
motility was investigated. Because VSM induced an in-
creased formation of stress fibers (Fig. 6), the influence
on cell migration and invasion was determined (Fig. 8b, c).
Concentrations of 25–50 μg/ml VSM decreased the
migratory activity (90 %) and the invasiveness (35 %) of
MG-63 cells. BORM did not alter the cell motility, sig-
nificantly but induced apoptotic signals by enhanced
BCL-2 expression and proliferation reduction by PCNA
repression (Fig. 8d).
Discussion
In this study, eight samples from four Pakistani plant ex-
tracts were evaluated for their potential as anticancer
agents in selected human bone and breast cancer cell
lines in comparison with non-tumorigenic control cells
via cell viability measurements, cell cycle analysis, live
cell imaging and monitoring of metabolic as well as mo-
tility features. After the first initial screening, BORM
and VSM revealed the highest potential with regard to
its antitumor activity. Both extracts caused a significant
reduction of cell viability in the breast and bone cancer
cells. However, BORM also induced a strong reduction
of cell viability in the primary osteoblasts (POB), as well
as VSM lowered the cell vitality in the non-tumorigenic
breast cell line MCF-12A. But, VSM caused no negative
influence on POBs wherein the bone cancer cell lines
were strongly influenced (Fig. 1). These results suggest
that the therapeutic use of VSM particularly for the
treatment of bone cancer would be possible. For the
treatment of breast cancer the BORM extract may be
suitable on the basis of the vitality studies. Because
BORM caused only a marginal effect on the vitality of
the control cell line MCF-12A and induces a significant
vitality reduction in both, the estrogen receptor-positive
breast cancer cell line MCF-7 and in the triple-negative
cell line BT-20.
Subsequent cell cycle analysis revealed a substantial
increase of the proliferative phases G2/M and S after
exposure to 50 μg/mg VSM whereas BORM slightly
lowered the proliferation (Fig. 2a-b; exemplarily illus-
trated at the bone cancer cell line MG-63). Although
VSM especially increases the G2/M phase in MG-63
cells, a simultaneous increase in DNA strand breaks, to
be mentioned in the sub-G1 phase (Fig. 2c), could be
observed. This suggests that the VSM extract induces
apoptotic changes which are often associated with ele-
vated proliferation rates in order to obtain the cell layer.
Another possibility is a G2/M arrest of the cell popula-
tion similar to the effect of paclitaxel which stabilizes
tubulin polymerization resulting in arrest in mitosis and
apoptotic cell death [53].
So far, the obtained results imply that the extracts
VSM and BORM mediate different cellular responses
which lead to cytotoxic events. In order to identify these
cellular mechanisms, dose-response curves were created
first (Figs. 3 and 4). From these curves it can be con-
cluded that both extracts exert concentration-dependent
effects on both, breast as well as bone cancer cells. The
calculated IC50 values (Table 2) show that VSM prima-
rily affects the bone cancer cells and only minimally
impaired the vitality of healthy osteoblasts. The IC50
values of BORM illustrate that this extract reduces the
vitality of the breast cancer cell, predominantly. For the
non-tumorigenic control cell line MCF-12A a consider-
ably higher IC50 value was determined.
However, bright field, scanning electron and laser
scanning microscopy observations revealed morpho-
logical and structural alterations of MG-63 osteoblastic
cells after exposure to 100 μg/ml VSM or BORM (Fig. 6).
In comparison to the control, VSM treated MG-63 cells
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Fig. 8 (See legend on next page.)
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exhibit a prolonged shape accompanied with reduced
cell-cell contacts. F-actin staining revealed a strong in-
duction of stress fiber formation through the entire cells.
Along with the reduced cell viability, the mediated G2/
M arrest in the cell cycle phases and increased actin
fiber formation can be assumed that the VSM extract
causes a stabilization of the tumor cells, thus causing the
cytotoxic properties. In contrast, the BORM extract pro-
motes the formation of vesicle-like structures in the cell
which can be due to a stimulation of the lysosomal ac-
tivity or aggregation of lysosomal vesicles. Even at low
concentration (1–10 μg/ml BORM) an increased forma-
tion of lysosomes was observed (Fig. 7). The higher the
BORM concentrations, the greater the expansion of the
lysosomal compartments. At the highest concentration
(100 μg/ml) the lysosomes are large clusters around the
nucleus (Fig. 7). This means that the cytotoxic effect of
BORM is due to the activation of lysosomes which can
selectively activate programmed cell death [54]. Briefly,
lysosomal ROS generation can cause lysosomal mem-
brane permeabilization, whereby lysosomal cathepsins,
as well as other hydrolytic enzymes, are released from
the lysosomal lumen to the cytosol, and can trigger pro-
grammed cell death [55, 56]. In addition, BORM caused
a stronger granularisation and formation of Golgi vesi-
cles as well as a diffuse distribution of neutral lipids.
This is not surprising, because it is thought that the res-
ervoir of chemicals in the lysosome can be ‘topped up’
by supplies from the Golgi apparatus. The chemicals are
manufactured in the endoplasmic reticulum, modified in
the Golgi apparatus and transported to the lysosomes in
vesicles (sealed droplets). Modification in the Golgi ap-
paratus includes ‘destination labeling’ at a molecular
level ensuring that the vesicle is delivered to a lysosome
and not to the plasma membrane or elsewhere. The
‘label’ is returned to the Golgi apparatus for re-use
(http://bscb.org/ Society for Cell Biology.org). This sug-
gests that BORM primarily affects cell metabolism by
the disruption of lysosomal function and thus initiating
cell death. This view is supported by the changes in the
apoptotic signaling cascades, i.e. the upregulation of Bcl-
2 expression and further confirmed by a nearly complete
reduction of mitochondrial O2 consumption (Fig. 8).
Although the treatment with VSM also resulted in a sig-
nificant reduction in respiration rate, the underlying
mechanisms are different. Because of the stabilization of
the actin cytoskeleton, the MG-63 cells are limited in
their motility and can no longer divide, so that a G2/M
arrest is forced.
Conclusions
In this study two Pakistani plant extracts, namely VSM
and BORM could be identified as potential anti-tumor
agents at least on the bone and breast cancer cell lines
in vitro. The mechanism of action of VSM is achieved by
a cell cycle arrest in the G2/M phase and the stabilization
of the cell by increased actin stress fiber formation. The
antitumor effect of BORM is mediated by activating the
lysosomal induced cell death pathway. However, both
plant extracts exhibit strong cytotoxic potential in a con-
centration dependent manner. In this case VSM displayed
the least impact on primary osteoblast functioning as
non-tumorigenic cells whereas BORM showed the lowest
cytotoxic effect on the mammary control cell line. There-
fore, based on these results, we can postulate that VSM
can be of interest for the treatment of bone tumors and
BORM for the treatment of breast cancer. To prove this
assertion, future work is on the identification of potential
antitumor ingredients of these extracts and the evaluation
of the dose-response relationships, in vitro and in vivo.
Additional files
Additional file 1: Figure S1. Control cell cycle analysis. Histogram of
cell cycle phases in MG-63 cells after treatment with 0.1 % of the control
substances (DMSO, MeOH, EtOH) in comparison with untreated cells,
cultivated in assay medium. No significant effect on the cell cycle phases,
mediated by the solvents used in this study could be observed. (TIF 645 kb)
Additional file 2: Figure S2. Bright field imaging of cell morphology.
Bright field images of MG-63 cells after exposure to VSM or BORM
(concentration series ranging from 1 to 100 μg/ml) for 48 h in comparison
with the control treatment. (TIF 12518 kb)
Additional file 3: Figure S3. Imaging of actin cytoskeleton. Laser scanning
microscopic images of F-actin (red) and Hoechst (blue) stained MG-63 cells
after exposure to VSM or BORM (concentration series ranging from 1 to
100 μg/ml) for 48 h in comparison with the control treatment. (TIF 12140 kb)
Additional file 4: Figure S4. Live cell imaging of lysosomes. Laser
scanning microscopic images of lysosomes (green) in MG-63 cells after
(See figure on previous page.)
Fig. 8 Influence on O2 consumption, motility and selected protein marker expression. a Mitochondrial O2 consumption (respiration) in MG-63 cells
and primary osteoblasts (POB) during exposure to 25 μg/ml VSM or BORM in comparison to the control (which was set to 100 %) determined by the
Bionas® 2500 analyzing system combined with the metabolic chip Bionas DisocveryTM SC1000 equipped with Clark-type oxygen sensors. Both BORM
and VSM reduce the respiration rate dramatically (99 and 60 % reduction, respectively) in tumorigenic osteoblasts. b Effect of VSM (25, 50 μg/ml) on
MG-63 migration behavior in comparison to the control treatment (DMSO) in a 72 h time period in a wound healing assay (raw data available in
Additional file 7: Figure S7). Notably, exposure to VSM prevents migration of MG-63 cells so that the cell lawn cannot be closed. c Invasion assay
of BORM and VSM treated MG-63 cells. Only VSM reduced the invasion capacity, significantly. Mean ± SD, n = 3, *P < 0.5, significantly different
compared to control, unpaired t-test. d Western blot analysis of proliferation (PCNA) and apoptosis (Bcl-2) marker expression in VSM or BORM
treated (concentration series 1–50 μg/ml) MG-63 cells in comparison to the control (c). The stain free image of the polyacrylamide gel functions
as loading control
Engel et al. BMC Complementary and Alternative Medicine  (2016) 16:244 Page 16 of 18
treatment with 1–100 μg/ml BORM. Lysosomes were labeled with
LysoTracker® Green DND-26 (Molecular Probes, Carlsbad, CA, USA). Cell
nuclei (blue) were labeled with Hoechst. Notably, lysosome amount
increased with rising BORM concentration. (TIF 6162 kb)
Additional file 5: Figure S5. Metabolic live cell monitoring. Live cell
monitoring of three metabolic parameters (extracellular acidification,
mitochondrial O2 consumption and cell impedance) in MG-63 cells and
primary osteoblasts (POB) during exposure to 25 μg/ml VSM or BORM in
comparison to the control (which was set to 100 %) determined by the
Bionas® 2500 analyzing system combined with the metabolic chip Bionas
DisocveryTM SC1000. (TIF 1735 kb)
Additional file 6: Figure S6. Wound healing assay. Raw data of the
wound healing assay of VSM (25, 50 μg/ml) treated MG-63 cells. (TIF 10288 kb)
Additional file 7: Figure S7. Apoptosis detection. Annexin V/PI labeling
of VSM and BORM (50, 100 μg/ml) treated MG-63 cells. (TIF 1742 kb)
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